119 related articles for article (PubMed ID: 38126112)
1. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation.
Qian S; Liu J; Liao W; Wang F
Epigenomics; 2023 Dec; 15(23):1237-1255. PubMed ID: 38126112
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of METTL14-mediated m
Gong S; Wang S; Shao M
J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
5. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.
Li M; Wang Q; Zhang X; Yan N; Li X
Cell Cycle; 2021 Jul; 20(13):1279-1294. PubMed ID: 34097560
[TBL] [Abstract][Full Text] [Related]
6. METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression.
Qian S; Liu J; Liao W; Wang F
Genes Genomics; 2024 Feb; 46(2):213-229. PubMed ID: 37594665
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
Gong Y; Luo G; Zhang S; Chen Y; Hu Y
Cell Signal; 2024 May; 117():111068. PubMed ID: 38286198
[TBL] [Abstract][Full Text] [Related]
8. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
Liu J; Jiang K
J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
[TBL] [Abstract][Full Text] [Related]
9. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes IL-1β-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.
Xiao L; Zhao Q; Hu B; Wang J; Liu C; Xu H
J Cell Mol Med; 2020 Dec; 24(23):14013-14025. PubMed ID: 33098220
[TBL] [Abstract][Full Text] [Related]
11. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
12. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
[TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
Huang Y; Guan Y; Zhang X
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37498409
[TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
15. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
18. METTL3-mediated m6A modification promotes processing and maturation of
Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
[TBL] [Abstract][Full Text] [Related]
19. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.
Wu H; Li F; Zhu R
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):304-316. PubMed ID: 33355622
[TBL] [Abstract][Full Text] [Related]
20. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
Zhang Y; Liu S; Zhao T; Dang C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]